Skip to main content
Top
Published in: Rheumatology International 9/2008

01-07-2008 | Case Report

Longstanding epileptic encephalopathy and linear localized scleroderma: two distinct pathologic processes in an adolescent

Authors: Donato Rigante, Domenica Battaglia, Ilaria Contaldo, Ilaria La Torraca, Laura Avallone, Stefania Gaspari, Giulia Bersani, Achille Stabile

Published in: Rheumatology International | Issue 9/2008

Login to get access

Abstract

We report a 7-year-old boy who unexpectedly developed a multi-drug resistant epilepsy with negative neuroimaging results, followed by the insidious appearance of linear localized scleroderma involving the right leg. When the boy was 16 and severely affected by epileptic encephalopathy, we have evaluated this case for the first time: his localized scleroderma had reached the right buttock and positive anti-nuclear antibody was the only positive laboratory test. Methotrexate administered for 12 months was ineffective in improving both the organization of his electroencephalographic pattern and seizure control, though seemed to stabilize the progression of linear scleroderma. This report suggests that neurological abnormality and extracranial scleroderma might represent two own distinct processes in a same patient.
Literature
1.
go back to reference Uziel Y, Miller MR, Laxer RM (1995) Scleroderma in children. Pediatr Clin North Am 42:1171–1203PubMed Uziel Y, Miller MR, Laxer RM (1995) Scleroderma in children. Pediatr Clin North Am 42:1171–1203PubMed
2.
go back to reference Peterson LS, Nelson AM, Su WP, Mason T, O’Fallon WM, Gabriel SE (1997) The epidemiology of morphea (localized scleroderma) in Olmsted County 1960–1993. J Rheumatol 24:73–80PubMed Peterson LS, Nelson AM, Su WP, Mason T, O’Fallon WM, Gabriel SE (1997) The epidemiology of morphea (localized scleroderma) in Olmsted County 1960–1993. J Rheumatol 24:73–80PubMed
3.
go back to reference Zulian F, Woo P, Athreya BH, Laxer RM, Medsger TA Jr, Lehman TJ, Cerinic MM, Martini G, Ravelli A, Russo R, Cuttica R, de Oliveira SK, Denton CP, Cozzi F, Foeldvari I, Ruperto N (2007) The Pediatric rheumatology european society/american college of rheumatology/european league against rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum 57:203–212PubMedCrossRef Zulian F, Woo P, Athreya BH, Laxer RM, Medsger TA Jr, Lehman TJ, Cerinic MM, Martini G, Ravelli A, Russo R, Cuttica R, de Oliveira SK, Denton CP, Cozzi F, Foeldvari I, Ruperto N (2007) The Pediatric rheumatology european society/american college of rheumatology/european league against rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum 57:203–212PubMedCrossRef
4.
go back to reference Zulian F, Athreya BH, Laxer R, Nelson AM, Feitosa de Oliveira SK, Punaro MG, Cuttica R, Higgins GC, Van Suijlekom-Smit LW, Moore TL, Lindsley C, Garcia-Consuegra J, Esteves Hilario MO, Lepore L, Silva CA, Machado C, Garay SM, Uziel Y, Martini G, Foeldvari I, Peserico A, Woo P, Harper J (2006) Juvenile Scleroderma working group of the pediatric rheumatology european society juvenile localized scleroderma: clinical and epidemiological features in 750 children. an international study. Rheumatology 45:614–620PubMedCrossRef Zulian F, Athreya BH, Laxer R, Nelson AM, Feitosa de Oliveira SK, Punaro MG, Cuttica R, Higgins GC, Van Suijlekom-Smit LW, Moore TL, Lindsley C, Garcia-Consuegra J, Esteves Hilario MO, Lepore L, Silva CA, Machado C, Garay SM, Uziel Y, Martini G, Foeldvari I, Peserico A, Woo P, Harper J (2006) Juvenile Scleroderma working group of the pediatric rheumatology european society juvenile localized scleroderma: clinical and epidemiological features in 750 children. an international study. Rheumatology 45:614–620PubMedCrossRef
5.
go back to reference Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, Espada G, Corona F, Mukamel M, Vesely R, Musiej-Nowakowska E, Chaitow J, Ros J, Apaz M, Gerloni V, Makur-Zielinska H, Nielsen S, Ullman S, Horneff G, Wouters C, Martini G, Cimaz R, Laxer R, Athreya B (2005) Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 52:2873–2881PubMedCrossRef Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, Espada G, Corona F, Mukamel M, Vesely R, Musiej-Nowakowska E, Chaitow J, Ros J, Apaz M, Gerloni V, Makur-Zielinska H, Nielsen S, Ullman S, Horneff G, Wouters C, Martini G, Cimaz R, Laxer R, Athreya B (2005) Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 52:2873–2881PubMedCrossRef
6.
go back to reference Holland KE, Steffes B, Nocton JJ, Schwabe MJ, Jacobson RD, Drolet BA (2006) Linear scleroderma en coupe de sabre with associated neurologic abnormalities. Pediatrics 117:e132–136PubMedCrossRef Holland KE, Steffes B, Nocton JJ, Schwabe MJ, Jacobson RD, Drolet BA (2006) Linear scleroderma en coupe de sabre with associated neurologic abnormalities. Pediatrics 117:e132–136PubMedCrossRef
7.
go back to reference Blaszczyk M, Krolicki L, Krasu M, Glinska O, Jablonska S (2003) Progressive facial hemitrophy: central nervous system involvement and relationship with scleroderma en coup de sabre. J Rheumatol 30:1997–2004PubMed Blaszczyk M, Krolicki L, Krasu M, Glinska O, Jablonska S (2003) Progressive facial hemitrophy: central nervous system involvement and relationship with scleroderma en coup de sabre. J Rheumatol 30:1997–2004PubMed
8.
go back to reference Piette WW, Dorsey JK, Foucar E (1985) Clinical and serological expression of localized scleroderma. Case report and review of the literature. J Am Acad Dermatol 13(2Pt2):342–350PubMedCrossRef Piette WW, Dorsey JK, Foucar E (1985) Clinical and serological expression of localized scleroderma. Case report and review of the literature. J Am Acad Dermatol 13(2Pt2):342–350PubMedCrossRef
9.
go back to reference Birdi N, Laxer RM, Thorner P, Fritzler MJ, Silverman D (1993) Localized scleroderma progressing to sysytemic disease: case report and review of the literature. Arthritis Rheum 36:410–415PubMedCrossRef Birdi N, Laxer RM, Thorner P, Fritzler MJ, Silverman D (1993) Localized scleroderma progressing to sysytemic disease: case report and review of the literature. Arthritis Rheum 36:410–415PubMedCrossRef
10.
11.
go back to reference Kanzato N, Matsuzaki T, Komine Y, Saito M, Saito A, Yoshio T, Suehara M (1999) Localized scleroderma associated with progressing ischemic stroke. J Neurol Sci 163:86–89PubMedCrossRef Kanzato N, Matsuzaki T, Komine Y, Saito M, Saito A, Yoshio T, Suehara M (1999) Localized scleroderma associated with progressing ischemic stroke. J Neurol Sci 163:86–89PubMedCrossRef
12.
go back to reference Chung M, Sum J, Morrell M, Horoupian D (1995) Intracerebral involvement in scleroderma “en coup de sabre”: report of a case with neuropathologic findings. Ann Neurol 37:679–681PubMedCrossRef Chung M, Sum J, Morrell M, Horoupian D (1995) Intracerebral involvement in scleroderma “en coup de sabre”: report of a case with neuropathologic findings. Ann Neurol 37:679–681PubMedCrossRef
13.
go back to reference Sathornsumetee S, Schanberg L, Rabinovich E, Lewis D Jr, Weisleder P (2005) Parry-Romberg syndrome with fatal brain stem involvement. J Pediatr 146:429–431PubMedCrossRef Sathornsumetee S, Schanberg L, Rabinovich E, Lewis D Jr, Weisleder P (2005) Parry-Romberg syndrome with fatal brain stem involvement. J Pediatr 146:429–431PubMedCrossRef
14.
go back to reference Paprocka J, Jamroz E, Adamek D, Marszal E, Mandera M (2006) Difficulties in differentiation of Parry-Romberg syndrome, unilateral facial sclerodermia, and Rasmussen syndrome. Child’s Nerv Syst 22:409–415CrossRef Paprocka J, Jamroz E, Adamek D, Marszal E, Mandera M (2006) Difficulties in differentiation of Parry-Romberg syndrome, unilateral facial sclerodermia, and Rasmussen syndrome. Child’s Nerv Syst 22:409–415CrossRef
15.
go back to reference Holl-Wieden A, Klink T, Klink J, Warmuth-Metz M, Girschick HJ (2006) Linear scleroderma “en coup de sabre” associated with cerebral and ocular vasculitis. Scand J Rheumatol 35:402–404PubMedCrossRef Holl-Wieden A, Klink T, Klink J, Warmuth-Metz M, Girschick HJ (2006) Linear scleroderma “en coup de sabre” associated with cerebral and ocular vasculitis. Scand J Rheumatol 35:402–404PubMedCrossRef
16.
go back to reference Appenzeller S, Montenegro MA, Dertkigil SS, Sampaio-Barros PD, Marques-Neto JF, Samara AM, Andermann F, Cendes F (2004) Neuroimaging findings in scleroderma en coup de sabre. Neurology 62:1585–1589PubMed Appenzeller S, Montenegro MA, Dertkigil SS, Sampaio-Barros PD, Marques-Neto JF, Samara AM, Andermann F, Cendes F (2004) Neuroimaging findings in scleroderma en coup de sabre. Neurology 62:1585–1589PubMed
17.
go back to reference Flores-Alvarado DE, Esquivel-Valerio JA, Garza-Elizondo M, Espinoza LR (2003) Linear scleroderma en coup de sabre and brain calcification: is there a pathogenic relationship ? J Rheumatol 30:193–195PubMed Flores-Alvarado DE, Esquivel-Valerio JA, Garza-Elizondo M, Espinoza LR (2003) Linear scleroderma en coup de sabre and brain calcification: is there a pathogenic relationship ? J Rheumatol 30:193–195PubMed
18.
go back to reference Grosso S, Fioravanti A, Biasi G, Conversano E, Marcolongo R, Morgese G, Balestri P (2003) Linear scleroderma associated with progressive brain atrophy. Brain Dev 25:57–61PubMedCrossRef Grosso S, Fioravanti A, Biasi G, Conversano E, Marcolongo R, Morgese G, Balestri P (2003) Linear scleroderma associated with progressive brain atrophy. Brain Dev 25:57–61PubMedCrossRef
19.
go back to reference Dupont S, Catala M, Hasboun D, Semah F, Baulac M (1997) Progressive facial hemiatrophy and epilepsy: a common underlying dysgenetic mechanism. Neurology 48:1013–1018PubMed Dupont S, Catala M, Hasboun D, Semah F, Baulac M (1997) Progressive facial hemiatrophy and epilepsy: a common underlying dysgenetic mechanism. Neurology 48:1013–1018PubMed
20.
go back to reference Pupillo G, Andermann F, Dubeau F (1996) Linear scleroderma and intractable epilepsy: neuropathological evidence for a chronic inflammatory process. Ann Neurol 39:277–278PubMedCrossRef Pupillo G, Andermann F, Dubeau F (1996) Linear scleroderma and intractable epilepsy: neuropathological evidence for a chronic inflammatory process. Ann Neurol 39:277–278PubMedCrossRef
21.
go back to reference Stone J, Franks AJ, Guthrie JA, Johnson MH (2001) Scleroderma “en coup de sabre”: pathological evidence of intracerebral inflammation. J Neurol Neurosurg Psychiatry 70:382–385PubMedCrossRef Stone J, Franks AJ, Guthrie JA, Johnson MH (2001) Scleroderma “en coup de sabre”: pathological evidence of intracerebral inflammation. J Neurol Neurosurg Psychiatry 70:382–385PubMedCrossRef
22.
go back to reference Fitch PG, Rettig P, Burnham JM, Finkel TH, Yan AC, Akin E, Cron RQ (2006) Treatment of pediatric localized scleroderma with methotrexate. J Rheumatol 33:609–614PubMed Fitch PG, Rettig P, Burnham JM, Finkel TH, Yan AC, Akin E, Cron RQ (2006) Treatment of pediatric localized scleroderma with methotrexate. J Rheumatol 33:609–614PubMed
23.
go back to reference Rosenkranz ME, Agle LM, Efthimiou P, Lehman TJ (2006) Systemic and localized scleroderma in children: current and future treatment options. Paediatr Drugs 8:85–97PubMedCrossRef Rosenkranz ME, Agle LM, Efthimiou P, Lehman TJ (2006) Systemic and localized scleroderma in children: current and future treatment options. Paediatr Drugs 8:85–97PubMedCrossRef
24.
go back to reference Uziel Y, Feldman BM, Krafchik BR, Yeung RS, Laxer RM (2000) Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr 136:91–95PubMedCrossRef Uziel Y, Feldman BM, Krafchik BR, Yeung RS, Laxer RM (2000) Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr 136:91–95PubMedCrossRef
25.
go back to reference Seyger MMB, van der Hoogen FHJ, de Boo T, de Jong EMGJ (1998) Low-dose methotrexate in the treatment of wide-spread morphea. J Am Acad Dermatol 39:220–225PubMedCrossRef Seyger MMB, van der Hoogen FHJ, de Boo T, de Jong EMGJ (1998) Low-dose methotrexate in the treatment of wide-spread morphea. J Am Acad Dermatol 39:220–225PubMedCrossRef
26.
go back to reference Billiau AD, Wouters CH, Lagae LG (2005) Epilepsy and the immune system: is there a link ? Eur J Paediatr Neurol 9:29–42PubMedCrossRef Billiau AD, Wouters CH, Lagae LG (2005) Epilepsy and the immune system: is there a link ? Eur J Paediatr Neurol 9:29–42PubMedCrossRef
27.
go back to reference Peltola JT, Haapala A, Isojärvi JI, Auvinen A, Palmio J, Latvala K, Kulmala P, Laine S, Vaarala O, Keränen T (2000) Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. Am J Med 109:712–717PubMedCrossRef Peltola JT, Haapala A, Isojärvi JI, Auvinen A, Palmio J, Latvala K, Kulmala P, Laine S, Vaarala O, Keränen T (2000) Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. Am J Med 109:712–717PubMedCrossRef
28.
go back to reference Callenbach PM, Jol-Van Der Zijde CM, Geerts AT, Arts WF, Van Donselaar CA, Peters AC, Stroink H, Brouwer OF, Van Tol MJ (2003) Dutch Study of Epilepsy in Childhood Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood. Clin Exp Immunol 132:144–151PubMedCrossRef Callenbach PM, Jol-Van Der Zijde CM, Geerts AT, Arts WF, Van Donselaar CA, Peters AC, Stroink H, Brouwer OF, Van Tol MJ (2003) Dutch Study of Epilepsy in Childhood Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood. Clin Exp Immunol 132:144–151PubMedCrossRef
Metadata
Title
Longstanding epileptic encephalopathy and linear localized scleroderma: two distinct pathologic processes in an adolescent
Authors
Donato Rigante
Domenica Battaglia
Ilaria Contaldo
Ilaria La Torraca
Laura Avallone
Stefania Gaspari
Giulia Bersani
Achille Stabile
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 9/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0541-8

Other articles of this Issue 9/2008

Rheumatology International 9/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine